Moxifloxacin monotherapy on par with combination therapy in CAP

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1539, 2006-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Moxifloxacin: sequential therapy produces rapid improvements in CAP

Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis

By Dawson Rodney Diacon Andreas

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 927-932

Informa Healthcare

Access to resources Recommend Favorite

Moxifloxacin dominates for CAP

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 539, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Aliskiren: A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension

By Duggan Sean T. Chwieduk Claudine M. Curran Monique P.

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 2011-2049

Adis International

Access to resources Recommend Favorite

Monotherapy versus Combination Therapy as First Line Treatment of Uncomplicated Arterial Hypertension

By Ruzicka M.

Drugs, Vol. 61, Iss. 7, 2001-01 ,pp. : 943-954

Adis International

Access to resources Recommend Favorite